Designing AML Panel for Clinical Testing
Presentation from PMWC - Duke University, May 2017
Presented at the Precision Medicine World Conference (PMWC) at Duke University on May 24, 2017, this presentation provides an overview of designing an Acute Myeloid Leukemia Panel, including where to start, AML biomarker considerations and utilizing the back-end database.
Download the presentation to learn more about determining the ability to hunt biomarkers based on importance of publication; driving gene association to diagnostic testing and treatment related; and supporting gene selection due to publication prevalence.
Victor Weigman, Ph.D., Director, Translational Genomics